Safety and efficacy of low-dose methotrexate for the treatment of refractory sclerodermatous chronic graft-versus-host disease: a single institution retrospective study

被引：0
|
作者：
Giavedoni, P. [1 ,2 ]
Mascaro, J. M. [1 ,2 ]
Rovira, M. [3 ]
Fernandez-Aviles, F. [3 ]
Gutierrez, G. [3 ]
Rosinol, L. [3 ]
Suarez-Lledo, M. [3 ]
Martinez, C. [3 ]
机构：
[1] Univ Barcelona, Dept Dermatol, Barcelona, Spain
[2] Univ Barcelona, Hematopoiet Stem Cell Transplantat Unit, Barcelona, Spain
[3] Univ Barcelona, Dept Hematol, Hosp Clin, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P217
引用
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [1] Treatment of refractory chronic graft-versus-host disease with low-dose methotrexate
    Battista, M. L.
    Patriarca, F.
    Sperotto, A.
    Zaja, F.
    Medeot, M.
    Cerno, M.
    Fanin, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S225 - S225
  • [2] Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
    Giaccone, L
    Martin, P
    Carpenter, P
    Moravec, C
    Hooper, H
    Funke, VAM
    Storb, R
    Flowers, MED
    BONE MARROW TRANSPLANTATION, 2005, 36 (04) : 337 - 341
  • [3] Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease
    L Giaccone
    P Martin
    P Carpenter
    C Moravec
    H Hooper
    V A M Funke
    R Storb
    M E D Flowers
    Bone Marrow Transplantation, 2005, 36 : 337 - 341
  • [4] Safety and potential efficacy of low dose methotrexate for treatment of chronic graft-versus-host disease.
    Flowers, MED
    Giaccone, L
    Funke, V
    Carpenter, PA
    Moravec, C
    Hooper, H
    Storb, RF
    Martin, PJ
    BLOOD, 2004, 104 (11) : 361B - 361B
  • [5] Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease
    Yakoub-Agha, Ibrahim
    Magro, Leonardo
    Catteau, Benoit
    Willekens, Christophe
    Coiteux, Valerie
    Bruno, Benedicte
    Terriou, Louis
    Jouet, Jean-Pierre
    BLOOD, 2008, 112 (11) : 745 - 746
  • [6] Low-dose methotrexate for treatment of severe and overlap chronic graft-versus-host disease
    Levati, G.
    Greco, R.
    Sala, E.
    Guggiari, E.
    Malato, S.
    Marktel, S.
    Carrabba, M. G.
    Claudiani, S.
    Marcatti, M.
    Lunghi, F.
    Assanelli, A.
    Bernardi, M.
    Peccatori, J.
    Corti, C.
    Ciceri, F.
    Lupo-Stanghellini, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S448 - S449
  • [7] Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease
    Hurabielle, C.
    de Fontbrune, F. Sicre
    Moins-Teisserenc, H.
    Robin, M.
    Jachiet, M.
    Coman, T.
    Dhedin, N.
    Cassius, C.
    Chasset, F.
    de Masson, A.
    Michonneau, D.
    Bagot, M.
    Bergeron, A.
    Socie, G.
    de Latour, R. Peffault
    Bouaziz, J-D
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E206 - E208
  • [8] Low-dose thoracoabdominal irradiation for the treatment of refractory chronic graft-versus-host disease
    Robin, M
    Guardiola, P
    Girinsky, T
    Hernandez, G
    Espérou, H
    Ribaud, P
    Rocha, V
    Garnier, F
    Socié, G
    Gluckman, E
    Devergie, AS
    TRANSPLANTATION, 2005, 80 (05) : 634 - 642
  • [9] TREATMENT OF REFRACTORY SCLERODERMATOUS GRAFT-VERSUS-HOST DISEASE WITH ETRETINATE
    MARCELLUS, DC
    FREEMER, CS
    FARMER, EB
    ALTOMONTE, V
    VOGELSANG, GB
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1106 - 1106
  • [10] Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab
    von Bonin, Malte
    Oelschlaegel, Uta
    Radke, Joergen
    Stewart, Michelle
    Ehninger, Gerhard
    Bornhauser, Martin
    Platzbecker, Uwe
    TRANSPLANTATION, 2008, 86 (06) : 875 - 879
12345